Search Results - "Meng, Qingcai"
-
1
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Published in Journal of hematology and oncology (10-08-2020)“…In recent years, cancer immunotherapy based on immune checkpoint inhibitors (ICIs) has achieved considerable success in the clinic. However, ICIs are…”
Get full text
Journal Article -
2
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
Published in Molecular cancer (11-10-2021)“…Cancer-associated fibroblasts (CAFs), a stromal cell population with cell-of-origin, phenotypic and functional heterogeneity, are the most essential components…”
Get full text
Journal Article -
3
TRIM14 Inhibits cGAS Degradation Mediated by Selective Autophagy Receptor p62 to Promote Innate Immune Responses
Published in Molecular cell (06-10-2016)“…Cyclic GMP-AMP synthase (cGAS) is an essential DNA virus sensor that triggers type I interferon (IFN) signaling by producing cGAMP to initiate antiviral…”
Get full text
Journal Article -
4
PARP inhibitors in pancreatic cancer: molecular mechanisms and clinical applications
Published in Molecular cancer (02-03-2020)“…Pancreatic cancer is a highly lethal disease with a poor prognosis, and existing therapies offer only limited effectiveness. Mutation gene sequencing has shown…”
Get full text
Journal Article -
5
Complex roles of the stroma in the intrinsic resistance to gemcitabine in pancreatic cancer: where we are and where we are going
Published in Experimental & molecular medicine (01-12-2017)“…Pancreatic ductal adenocarcinoma (PDAC) is among the most devastating human malignancies. The poor clinical outcome in PDAC is partly attributed to a…”
Get full text
Journal Article -
6
The reciprocal regulation between host tissue and immune cells in pancreatic ductal adenocarcinoma: new insights and therapeutic implications
Published in Molecular cancer (13-12-2019)“…Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death and is one of the most difficult-to-treat cancers. Surgical…”
Get full text
Journal Article -
7
Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294/c-Myc axis
Published in Molecular cancer (21-08-2021)“…Extensive studies have demonstrated the pivotal roles of circular RNAs (circRNAs) in the occurrence and development of different human cancers. However, the…”
Get full text
Journal Article -
8
Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2)
Published in Journal of experimental & clinical cancer research (10-08-2017)“…Pancreatic cancer is susceptible to gemcitabine resistance, and patients receive less benefit from gemcitabine chemotherapy. Previous studies report that…”
Get full text
Journal Article -
9
Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma
Published in Cellular and molecular life sciences : CMLS (01-07-2021)“…Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related death due to its late diagnosis that removes the opportunity for surgery…”
Get full text
Journal Article -
10
Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment
Published in Theranostics (2021)“…Pancreatic cancer (PC), an important cause of cancer-related deaths worldwide, is one of the most malignant cancers characterized by a dismal prognosis…”
Get full text
Journal Article Book Review -
11
Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
Published in International journal of molecular sciences (10-10-2021)“…The overall five-year survival rate of pancreatic cancer has hardly changed in the past few decades (less than 10%) because of resistance to all known…”
Get full text
Journal Article -
12
PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells
Published in Cancer research (Chicago, Ill.) (01-01-2019)“…: Kras is a decisive oncogene in pancreatic ductal adenocarcinoma (PDAC). PIN1 is a key effector involved in the Kras/ERK axis, synergistically mediating…”
Get full text
Journal Article -
13
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Published in Cancer communications (London, England) (01-01-2023)“…As a critical component of the tumor microenvironment (TME), cancer‐associated fibroblasts (CAFs) play important roles in cancer initiation and progression…”
Get full text
Journal Article -
14
The role of m6A-related genes in the prognosis and immune microenvironment of pancreatic adenocarcinoma
Published in PeerJ (San Francisco, CA) (28-09-2020)“…Pancreatic adenocarcinoma (PAAD) is among the most lethal diseases and has a dismal prognosis; however, efficient treatment is currently limited. Several…”
Get full text
Journal Article -
15
The promising role of noncoding RNAs in cancer-associated fibroblasts: an overview of current status and future perspectives
Published in Journal of hematology and oncology (19-11-2020)“…As the most important component of the stromal cell population in the tumor microenvironment (TME), cancer-associated fibroblasts (CAFs) are crucial players in…”
Get full text
Journal Article -
16
RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m6A-YTHDF2-dependent manner
Published in Oncogene (13-05-2022)“…RNA N6-methyladenosine (m 6 A) is an emerging regulator of mRNA modifications and represents a novel player in tumorigenesis. Although it has functional…”
Get full text
Journal Article -
17
Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
Published in Frontiers in immunology (10-03-2021)“…The treatment modalities for pancreatic ductal adenocarcinoma (PDAC) are limited and unsatisfactory. Although many novel drugs targeting the tumor…”
Get full text
Journal Article -
18
Diagnostic and prognostic value of carcinoembryonic antigen in pancreatic cancer: a systematic review and meta-analysis
Published in OncoTargets and therapy (01-01-2017)“…Carcinoembryonic antigen (CEA) is one of the most widely used tumor markers and is increased in 30%-60% of patients with pancreatic cancer. Although…”
Get full text
Journal Article -
19
ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis
Published in Redox biology (01-07-2024)“…Currently, chemotherapy remains occupying a pivotal place in the treatment of pancreatic ductal adenocarcinoma (PDAC). Nonetheless, the emergence of drug…”
Get full text
Journal Article -
20
Comprehensive analysis of the prognosis and immune infiltration landscape of RNA methylation-related subtypes in pancreatic cancer
Published in BMC cancer (21-07-2022)“…RNA methylation refers to a form of methyl modification in RNA that modulates various epigenetic alterations. Mounting studies have focused on its potential…”
Get full text
Journal Article